Press release
Australia Biosimilar Market Projected to Reach USD 5,512.5 Million by 2033
The latest report by IMARC Group, titled "Australia Biosimilar Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", offers a comprehensive analysis of the biosimilar market's growth. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry. The Australia biosimilar market size reached USD 741.6 million in 2024. Looking forward, IMARC Group expects the market to reach USD 5,512.5 million by 2033, exhibiting a growth rate (CAGR) of 22.20% during 2025-2033.Base Year: 2024
Forecast Years: 2025-2033
Historical Years: 2019-2024
Market Size in 2024: USD 741.6 Million
Market Forecast in 2033: USD 5,512.5 Million
Market Growth Rate 2025-2033: 22.20%
Australia Biosimilar Market Overview
Australia's biosimilar showcase is encountering critical development, driven by strong government arrangements, postings beneath the Pharmaceutical Benefits Conspire (PBS), and expanding request for cost-effective biologic medicines. The government's center on reasonable biologics has encouraged broader get to to progressed treatments whereas empowering competition among biosimilar engineers. This environment is cultivating more prominent acknowledgment among healthcare suppliers and patients, driving to upgraded accessibility and decreased treatment costs over the healthcare framework.
Request For Sample Report:
https://www.imarcgroup.com/australia-biosimilar-market/requestsample
Australia Biosimilar Market Trends and Drivers
The Australian biosimilar showcase is being formed by administrative bolster and national repayment methodologies. The government's center on reasonable biologics has empowered broader get to to progressed treatments whereas empowering competition among biosimilar designers. A key driver has been the Pharmaceutical Benefits Admonitory Committee (PBAC), which assesses solutions for subsidization beneath the Pharmaceutical Benefits Plot (PBS). These assessments are fundamental to guarantee patients get cost-effective medicines without compromising on quality. In May 2024, PBAC prescribed Amgen's Wezlana, the primary ustekinumab biosimilar, for PBS posting. This proposal taken after the product's endorsement by the Restorative Merchandise Organization (TGA) in January 2024. Wezlana was endorsed for Crohn's malady, ulcerative colitis, plaque psoriasis, and psoriatic arthritis-indications already served as it were by higher-cost originator items. This move signaled a turning point, empowering the integration of biosimilars into cutting edge treatment plans. The showcase has since seen more prominent acknowledgment among healthcare suppliers and moved forward accessibility over healthcare frameworks. As a result, patients presently have more reasonable choices, and biosimilar engineers pick up certainty to enter the Australian advertise. With proceeded PBAC supports and streamlined pathways for PBS postings, showcase members are anticipated to extend, boosting accessibility and decreasing treatment costs.
Australia Biosimilar Market Segmentation:
1. By Molecule:
• Infliximab
• Insulin Glargine
• Epoetin Alfa
• Etanercept
• Filgrastim
• Somatropin
• Rituximab
• Follitropin Alfa
• Adalimumab
• Pegfilgrastim
• Trastuzumab
• Bevacizumab
• Others
2. By Indication:
• Auto-Immune Diseases
• Blood Disorders
• Diabetes
• Oncology
• Growth Deficiency
• Female Infertility
• Others
3. By Manufacturing Type:
• In-house Manufacturing
• Contract Manufacturing
4. By Region:
• New South Wales
• Victoria
• Queensland
• South Australia
• Western Australia
• Tasmania
• Northern Territory
• Australian Capital Territory
Browse Full Report with TOC & List of Figures:
https://www.imarcgroup.com/australia-biosimilar-market
Australia Biosimilar Market News:
• May 2024: Amgen's Wezlana, the first ustekinumab biosimilar, was recommended by the Pharmaceutical Benefits Advisory Committee for listing under the Pharmaceutical Benefits Scheme.
• January 2024: The Therapeutic Goods Administration approved Wezlana for multiple indications, including Crohn's disease and plaque psoriasis.
Key Highlights of the Report:
1. Market Performance (2019-2024)
2. Market Outlook (2025-2033)
3. COVID-19 Impact on the Market
4. Porter's Five Forces Analysis
5. Strategic Recommendations
6. Historical, Current, and Future Market Trends
7. Market Drivers and Success Factors
8. SWOT Analysis
9. Structure of the Market
10. Value Chain Analysis
11. Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as part of the customization.
Ask analyst for your customized sample:
https://www.imarcgroup.com/request?type=report&id=31900&flag=E
Other report by Imarc Group -
https://www.imarcgroup.com/australia-distributed-energy-market
https://www.imarcgroup.com/australia-management-consulting-market
https://www.imarcgroup.com/mobile-virtual-network-operator-market
https://www.imarcgroup.com/australia-fantasy-sports-market
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91-120-433-0800
United States: +1-631-791-1145
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients across all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Australia Biosimilar Market Projected to Reach USD 5,512.5 Million by 2033 here
News-ID: 4060743 • Views: …
More Releases from IMARC Group

Acoustic Panels Manufacturing Plant Cost 2025: Project Report, Business Plan, Ra …
Setting up an acoustic panel manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Acoustic Panels Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing an acoustic panels…

Paper Napkin Manufacturing Plant 2025: Project Report, Business Plan, Raw Materi …
Setting up a paper napkin manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Paper Napkin Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a paper napkin…

Renewable Syngas Manufacturing Plant Cost 2025: Setup Details, Capital Investmen …
Setting up a renewable syngas manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Renewable Syngas Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a renewable syngas…

Generator Manufacturing Plant Report 2025: Project Details, Machinery Requiremen …
Setting up a generator manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Generator Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a generator manufacturing plant, covering…
More Releases for Australia
Derila Memory foam pillow Australia: Honest Reviews About Derila Australia
Derila is one of the best memory foam pillows sold in Australia today.
Priced at around 30 dollars (USD), derila is currently the most reviewed and the cheapest memory pillow available in Australia.
What is Derila? Is Derila Pillow the best in Australia? Keep reading to discover everything worth knowing about Derila Australia.
OVERVIEW
Recently, Memory foam pillow has been trending and there is a lot of brands to choose from. Which one is…
CeraCare Australia - Where to Buy Legit CeraCare Supplement in Australia?
CeraCare Australia - Ceracare is a glucose support supplement that proposes to augment cardiovascular prosperity and to stay aware of perfect glucose assimilation in Australia. CeraCare supplement is conceptualized and executed by a threesome – Christine, Dr. Jihn and Michael. It is a natural supplement that helps one stay aware of ideal glucose levels, cardiovascular prosperity, and glucose assimilation.
Take Advantage of 80% Discount Offer in Australia >> https://boostsxproaustralia.com/ceracare-new
The indications…
Glucofort Australia - Where to Buy Legit Glucofort Supplement in Australia?
Glucofort Australia - Glucofort is an efficient, all-natural progressive glucose support supplement in Australia. This formula is made out of 12 key ingredients, 7 nutrients, and minerals, and a little of Vanadium. This supplement upholds regulated glucose levels and glucose digestion. Glucofort prides itself as the most inventive supplements available in Oceania, accentuating its solidarity, wellbeing, and quality.
Take Advantage of 75% Discount Offer in Australia >> https://boostsxproaustralia.com/glucofort-new
Rather than simply…
Australia Agriculture Market, Australia Agriculture Industry, Australia Agricult …
Australia Agriculture has been as vital within the development of Australia, because it was within the United States. Australia's ancient dominance in wheat and sheep continues into the 21st century. Recently Australian agriculture has become more and more diversified. The considerable expanses of productive land have helped Australia to become a number one world exporter of grains, meats, and wool. Each grains (predominantly wheat and barley) and wool markets round…
Australia Conveyor Maintenance Analysis by Top Companies Habasit Australia Pty l …
Global Australia Conveyor Maintenance Market and Competitive Analysis
Know your current market situation! Not only a vital element for brand new products but also for current products given the ever-changing market dynamics. The study allows marketers to remain involved with current consumer trends and segments where they'll face a rapid market share drop. Discover who you actually compete against within the marketplace, with Market Share Analysis know market position, to push…
Australia Conveyor Maintenance Market Analysis By Manufacturers Rema Tip Top Aus …
A conveyor system is a common piece of mechanical handling device that moves materials/objects from one location. A conveyor is often lifeline to a company’s ability to effectively move its products in a timely manner. While it is used constantly in a manufacturing plant, proper maintenance from trained technicians can extend the lifespan of conveyor. Furthermore, conveyor maintenance is essential as it may be subjected to different types of failures…